Trends in fetal and infant deaths caused by congenital anomalies

ICBD (International Clearinghouse for birth Defects Monitoring Systems), 1991, 220 Centers for Disease Control and Prevention (CDC), 1995, Economic costs of birth defects and cerebral palsy-United States, 1992, MMWR Morb Mortal Wkly Rep, 44, 694 Holmes, 1997, Impact of the detection and prevention of developmental abnormalities in human studies, Reprod Toxicol, 11, 267, 10.1016/S0890-6238(96)00143-8 Sever, 1997, The impact of congenital malformation on public health, Int J Abnormal Development, 48, 547 Statistics Canada. Selected Infant Mortality Statistics, Canada 1921–1990. 1993 Catalogue No. 82-549 Wen, 2000, Patterns of infant mortality caused by congenital anomalies, Teratology, 61, 342, 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7 Health Statistics Division. Births and Deaths 1995. Ottawa: Statistics Canada: 1997. Catalogue No. 84-210-XIB Health Statistics Division. Births and Deaths 1996. Ottawa: Statistics Canada: 1999. Catalogue No. 84F210XPB. Health Statistics Division. Births and Deaths 1997. Ottawa: Statistics Canada: 1999. Catalogue No. 84F210XPB. Centers for Disease Control and Prevention (CDC), 1998, Trends in infant mortality attributable to birth defects—United States, 1980–1995, MMWR Morb Mortal Wkly Rep, 47, 773 Centers for Disease Control and Prevention (CDC), 1989, Contribution of birth defects to infant mortality—United States, MMWR Morb Mortal Wkly Rep, 38, 633 Singh, 1995, Infant mortality in the United States: trends, differentials, and projections, 1950 through 2010, Am J Public Health, 85, 957, 10.2105/AJPH.85.7.957 Lee, 2001, Infant mortality from congenital malformations in the United States, 1970–1997, Obstet Gynecol, 98, 620, 10.1016/S0029-7844(01)01507-1 Smith, 1991, Trends in mortality in Britain: 1920–1986, Ann Nutr Metab, 35, 53, 10.1159/000177678 Sachs, 1995, The impact of extreme prematurity and congenital anomalies on the interpretation of international comparisons of infant mortality, Obstet Gynecol, 85, 941, 10.1016/0029-7844(95)00056-W Williams, 1982, Identifying the sources of the recent decline in perinatal mortality rates in California, N Engl J Med, 306, 207, 10.1056/NEJM198201283060404 Goldenberg, 1983, Lethal congenital anomalies as a cause of birth-weight-specific neonatal mortality, JAMA, 250, 513, 10.1001/jama.250.4.513 Liu, 2001, Secular trends in congenital anomaly-related fetal and infant mortality in Canada, 1985–1996, Am J Med Gene, 104, 7, 10.1002/1096-8628(20011115)104:1<7::AID-AJMG10023>3.0.CO;2-B Liu, 2002, Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada, JAMA, 287, 1561, 10.1001/jama.287.12.1561 Fair, 1993, The Canadian birth data base: A new research tool to study reproductive outcome, Health Reports, 5, 281 Joseph, 1997, Recent trends in infant mortality rates and proportions of low-birth-weight live births in Canada, CMAJ, 157, 535 Joseph, 1999, Changes in the registration of stillbirths <500 g in Canada, 1985–95, Paediatr Perinat Epidemiol, 13, 278, 10.1046/j.1365-3016.1999.00191.x Hein, 1986, The changing pattern of neonatal mortality in a regionalized system of perinatal care, Am J Dis Child, 140, 989 Carmichael, 1998, Cause-specific trends in neonatal mortality among black and white infants, United States, 1980–1995, Matern Child Health J, 2, 67, 10.1023/A:1022916121368 Health Statistics Division, 1999 Dwyer, 1995, SIDS epidemiology and incidence, Pediatric Annals, 24, 350, 10.3928/0090-4481-19950701-06 Sullivan, 2001, Review of risk factors for sudden infant death syndrome, Paediatr Perinat Epidemiol, 15, 144, 10.1046/j.1365-3016.2001.00330.x Grandiean, 1999, The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study, Am J Obstet Gynecol, 181, 446, 10.1016/S0002-9378(99)70577-6 Turner, 1998, Folic acid fortification: What does it mean for patients and physicians, CMAJ, 158, 773 Forman, 1996, Folic acid and prevention of neural tube defects: a study of Canadian mothers of infants with spina bifida, Clin Invest Med, 19, 195 Vimercati, 2000, Prevalence and distribution of congenital cardiopathy at birth and in pregnancy termination: Impact of prenatal diagnosis in 4 years of experience, Acta Biomed Ateneo Parmense, 71, 487 Lin, 1999, Cardiovascular malformations: changes in prevalence and birth status, 1971–1990, Am J Med Genet, 84, 102, 10.1002/(SICI)1096-8628(19990521)84:2<102::AID-AJMG4>3.0.CO;2-G Garne, 2001, Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registrics, Ultrasound Obstet Gynecol, 17, 386, 10.1046/j.1469-0705.2001.00385.x Forrester, 1998, Impact of prenatal diagnosis and elective termination on the prevalence of selected birth defects in Hawaii, Am J Epidemiol, 148, 1201, 10.1093/oxfordjournals.aje.a009610 Haddow, 1998, Screening of maternal serum for fetal Down's syndrome in the first trimester, N Engl J Med, 338, 955, 10.1056/NEJM199804023381404 Velie, 1996, Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989–1991, Am J Epidemiol, 144, 473, 10.1093/oxfordjournals.aje.a008953 Boyd, 1988, 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK, Lancet, 352, 1577, 10.1016/S0140-6736(98)03202-4 Grandjean, 1998, Detection of chromosomal abnormalities, an outcome of ultrasound screening. The Eurofetus Team, Ann NY Acad Sci, 847, 136, 10.1111/j.1749-6632.1998.tb08934.x Cromie, 2001, Implications of prenatal ultrasound screening in the incidence of major genitourinary malformations, J Urol, 165, 1677, 10.1016/S0022-5347(05)66391-4